{"speaker":{"id":1214,"title":"","firstname":"Bill","middleinitial":"","lastname":"Doyle","description":"Engineer","whotheyare":"With his company Novocure, Bill Doyle works to bring breakthrough medical technologies to doctors and patients. ","whylisten":"<p>Bill Doyle is the executive chair of Novocure, a company commercializing a new therapeutic modality for solid tumors using low-intensity electric fields. Recently, Novocure received FDA approval for its first indication, recurrent Glioblastoma Multiforme (GBM), the most virulent form of brain cancer; it is now conducting additional clinical trials.  <\/p><p>In 2002, Doyle co-founded medical device venture firm WFD Ventures, which provides financing and business-building expertise to medical device companies with the potential to make a major impact on patient care, working with entrepreneurs, doctors and scientists to improve medical outcomes and maximize the potential of their innovations.<\/p><p>A graduate of MIT, Doyle stablished the MIT FIRST Scholarship for FIRST Robotics Competition participants admitted to MIT.<\/p><p>Watch Jay Walker&#39;s <a href=\"http:\/\/www.youtube.com\/watch?v=rD3Gdkhzj9s\" target=\"_blank\">onstage Q&amp;A with Bill Doyle &gt;&gt; <\/a> <\/p>","slug":"bill_doyle","published_at":"2012-01-31 15:55:00","updated_at":"2014-10-19 01:35:01"}}